Trilogy International Partners Inc T.TRL.WT.A

RE:RE:Question

[smittigator]

there is likely a darn good reason that the news is quiet on tefina, the ability of a major shareholder or rbc investment team to control stock price is a reality weather we like it or not. a release or movement forward on tefina will present a massive upside on this companies share price. rbc itself has a hugh position with this company. profit per share should come in on the plus side this quarter, hopefully we see some established income from endo on the natesto deal. we will no doubt be hearing something on tefina development on thursday, which is expected to be quite positive. by the time you here of tefina news it will be to late to jump back in. If tefina where to get approval, which the fda has hugh pressure on the u.s. side womens movement to develop something, we would then be looking at a significant buy out. the big players will cobble this company up. Phyzer would piggy back this with there products, Endo and them would have a bidding war. the next week of trading will tell the tale, today should like show a reverse in direction.